In8bio Inc Stock Buy Hold or Sell Recommendation
| INAB Stock | USD 0.32 0.01 3.03% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding In8bio Inc is 'Strong Sell'. Macroaxis provides In8bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding In8bio positions.
Check out In8bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as In8bio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
In8bio |
Execute In8bio Buy or Sell Advice
The In8bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on In8bio Inc. Macroaxis does not own or have any residual interests in In8bio Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute In8bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
In8bio Trading Alerts and Improvement Suggestions
| In8bio Inc generated a negative expected return over the last 90 days | |
| In8bio Inc has high historical volatility and very poor performance | |
| In8bio Inc has some characteristics of a very speculative penny stock | |
| In8bio Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bio Inc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| In8bio Inc has a poor financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company shares are held by company insiders |
In8bio Returns Distribution Density
The distribution of In8bio's historical returns is an attempt to chart the uncertainty of In8bio's future price movements. The chart of the probability distribution of In8bio daily returns describes the distribution of returns around its average expected value. We use In8bio Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of In8bio returns is essential to provide solid investment advice for In8bio.
| Mean Return | -0.1 | Value At Risk | -11.54 | Potential Upside | 6.67 | Standard Deviation | 12.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of In8bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
In8bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to In8bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that In8bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a In8bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.25 | |
β | Beta against Dow Jones | 1.17 | |
σ | Overall volatility | 12.35 | |
Ir | Information ratio | -0.02 |
In8bio Volatility Alert
In8bio Inc is displaying above-average volatility over the selected time horizon. In8bio Inc is a potential penny stock. Although In8bio may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in In8bio Inc. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on In8bio instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.In8bio Fundamentals Vs Peers
Comparing In8bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze In8bio's direct or indirect competition across all of the common fundamentals between In8bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as In8bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of In8bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare In8bio to competition |
| Fundamentals | In8bio | Peer Average |
| Return On Equity | -1.8 | -0.31 |
| Return On Asset | -0.78 | -0.14 |
| Current Valuation | 24.67 M | 16.62 B |
| Shares Outstanding | 72.48 M | 571.82 M |
| Shares Owned By Insiders | 21.55 % | 10.09 % |
| Shares Owned By Institutions | 46.45 % | 39.21 % |
| Number Of Shares Shorted | 1 M | 4.71 M |
| Price To Book | 2.70 X | 9.51 X |
| EBITDA | (28.5 M) | 3.9 B |
| Net Income | (30.01 M) | 570.98 M |
| Cash And Equivalents | 25.74 M | 2.7 B |
| Cash Per Share | 1.37 X | 5.01 X |
| Total Debt | 4.89 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 9.08 X | 2.16 X |
| Book Value Per Share | 0.58 X | 1.93 K |
| Cash Flow From Operations | (23.34 M) | 971.22 M |
| Short Ratio | 0.51 X | 4.00 X |
| Earnings Per Share | (0.74) X | 3.12 X |
| Target Price | 4.75 | |
| Number Of Employees | 39 | 18.84 K |
| Beta | -0.069 | -0.15 |
| Market Capitalization | 23.19 M | 19.03 B |
| Total Asset | 33.71 M | 29.47 B |
| Retained Earnings | (91.22 M) | 9.33 B |
| Working Capital | 19.23 M | 1.48 B |
| Net Asset | 33.71 M |
Note: Acquisition by Brandt Peter C. of 253164 shares of In8bio at 0.395 subject to Rule 16b-3 [view details]
In8bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as In8bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About In8bio Buy or Sell Advice
When is the right time to buy or sell In8bio Inc? Buying financial instruments such as In8bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having In8bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy Funds Thematic Idea Now
Energy Funds
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out In8bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.